Rituximab-induced regression of CREST-related calcinosis.

about

Systemic sclerosis: commonly asked questions by rheumatologists The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.Is rituximab an effective treatment of refractory calcinosis?

P2860

Q27021067-C359ABA0-6D88-4C5F-9D83-E30A91CE461E Q37427265-006246AF-B10F-4BA4-8BC7-4ADEA78B3AE5 Q51727055-7AE5A742-2C73-49B0-AC18-1C6143DDBC4C

P2860

Rituximab-induced regression of CREST-related calcinosis.

Item

http://www.wikidata.org/entity/Q51294294

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Rituximab-induced regression of CREST-related calcinosis.

@en

Rituximab-induced regression of CREST-related calcinosis.

@nl

type

Item

label

Rituximab-induced regression of CREST-related calcinosis.

@en

Rituximab-induced regression of CREST-related calcinosis.

@nl

prefLabel

Rituximab-induced regression of CREST-related calcinosis.

@en

Rituximab-induced regression of CREST-related calcinosis.

@nl

P1476

Rituximab-induced regression of CREST-related calcinosis.

@en

P2093

Carolina Muller

http://www.w3.org/2001/XMLSchema#string

Dayane Raquel de Paula

http://www.w3.org/2001/XMLSchema#string

Fabiane Barbero Klem

http://www.w3.org/2001/XMLSchema#string

Pedro Gabriel Lorencetti

http://www.w3.org/2001/XMLSchema#string

Valderilio Feijó Azevedo

http://www.w3.org/2001/XMLSchema#string

P2860

Calcinosis in rheumatic diseases.

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

Calcinosis cutis: part II. Treatment options.

Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature.

Cyclophosphamide versus placebo in scleroderma lung disease.

Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline.

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.

Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids.

Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.

P304

281-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-012-2124-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233769051

http://www.w3.org/2001/XMLSchema#string

P698

23179007

http://www.w3.org/2001/XMLSchema#string

Rituximab-induced regression of CREST-related calcinosis.

about

P2860

P2860

Rituximab-induced regression of CREST-related calcinosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698